[{"address1": "700 Quince Orchard Road", "city": "Gaithersburg", "state": "MD", "zip": "20878", "country": "United States", "phone": "240 268 2000", "website": "https://www.novavax.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.", "fullTimeEmployees": 1543, "auditRisk": 7, "boardRisk": 3, "compensationRisk": 6, "shareHolderRightsRisk": 5, "overallRisk": 5, "governanceEpochDate": 1717200000, "irWebsite": "http://www.novavax.com/go.cfm?do=Stock.GetQuote", "maxAge": 86400, "priceHint": 2, "previousClose": 14.06, "open": 14.0, "dayLow": 13.59, "dayHigh": 14.425, "regularMarketPreviousClose": 14.06, "regularMarketOpen": 14.0, "regularMarketDayLow": 13.59, "regularMarketDayHigh": 14.425, "beta": 1.95, "forwardPE": -21.875, "volume": 23829430, "regularMarketVolume": 23829430, "averageVolume": 15645424, "averageVolume10days": 15012970, "averageDailyVolume10Day": 15012970, "bid": 13.38, "ask": 14.07, "bidSize": 100, "askSize": 9100, "marketCap": 2062172032, "fiftyTwoWeekLow": 3.53, "fiftyTwoWeekHigh": 23.86, "priceToSalesTrailing12Months": 2.0691886, "fiftyDayAverage": 10.63, "twoHundredDayAverage": 6.8724, "currency": "USD", "enterpriseValue": 2066117760, "profitMargins": -0.40006, "floatShares": 122447343, "sharesOutstanding": 147298000, "sharesShort": 45291396, "sharesShortPriorMonth": 43769652, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.3075, "heldPercentInsiders": 0.050040003, "heldPercentInstitutions": 0.57967997, "shortRatio": 2.31, "shortPercentOfFloat": 0.39200002, "impliedSharesOutstanding": 147298000, "bookValue": -6.177, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -398707008, "trailingEps": -3.05, "forwardEps": -0.64, "pegRatio": 0.77, "lastSplitFactor": "1:20", "lastSplitDate": 1557446400, "enterpriseToRevenue": 2.073, "enterpriseToEbitda": -6.189, "52WeekChange": 1.0989506, "SandP52WeekChange": 0.26238096, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "NVAX", "underlyingSymbol": "NVAX", "shortName": "Novavax, Inc.", "longName": "Novavax, Inc.", "firstTradeDateEpochUtc": 818173800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "cdb3cddb-5091-3918-86d6-9b4894e61c6c", "messageBoardId": "finmb_350381", "gmtOffSetMilliseconds": -14400000, "currentPrice": 14.0, "targetHighPrice": 38.0, "targetLowPrice": 10.0, "targetMeanPrice": 22.8, "targetMedianPrice": 19.0, "recommendationMean": 2.3, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 480585984, "totalCashPerShare": 3.423, "ebitda": -333844992, "totalDebt": 581054016, "quickRatio": 0.624, "currentRatio": 0.904, "totalRevenue": 996609024, "revenuePerShare": 8.726, "returnOnAssets": -0.16322, "freeCashflow": -1195161600, "operatingCashflow": -471928992, "revenueGrowth": 0.159, "grossMargins": 0.049200002, "ebitdaMargins": -0.33498, "operatingMargins": -1.47814, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-24"}]